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Abstract
Iron-responsive manganese uptake is increased in iron-deficient rats, suggesting that toxicity related to manganese
exposure could be modified by iron status. To explore possible interactions, the distribution of intranasally-instilled
manganese in control and iron-deficient rat brain was characterized by quantitative image analysis using T1-weighted
magnetic resonance imaging (MRI). Manganese accumulation in the brain of iron-deficient rats was doubled after intranasal
administration of MnCl2 for 1- or 3-week. Enhanced manganese level was observed in specific brain regions of iron-deficient
rats, including the striatum, hippocampus, and prefrontal cortex. Iron-deficient rats spent reduced time on a standard
accelerating rotarod bar before falling and with lower peak speed compared to controls; unexpectedly, these measures of
motor function significantly improved in iron-deficient rats intranasally-instilled with MnCl2. Although tissue dopamine
concentrations were similar in the striatum, dopamine transporter (DAT) and dopamine receptor D1 (D1R) levels were
reduced and dopamine receptor D2 (D2R) levels were increased in manganese-instilled rats, suggesting that manganese-
induced changes in post-synaptic dopaminergic signaling contribute to the compensatory effect. Enhanced olfactory
manganese uptake during iron deficiency appears to be a programmed ‘‘rescue response’’ with beneficial influence on
motor impairment due to low iron status.
Citation: Kim J, Li Y, Buckett PD, Bo ¨hlke M, Thompson KJ, et al. (2012) Iron-Responsive Olfactory Uptake of Manganese Improves Motor Function Deficits
Associated with Iron Deficiency. PLoS ONE 7(3): e33533. doi:10.1371/journal.pone.0033533
Editor: Veronique Sgambato-Faure, INSERM/CNRS, France
Received November 29, 2011; Accepted February 10, 2012; Published March 30, 2012
Copyright:  2012 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported NIH Roadmap Training Grant R90 DK071507 (JK), by NIH grant K99 ES17781 (JK), and by National Institutes of Health grants
R03 DA027030 and R01 ES014638 (MWR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS
(National Institute of Environmental Health Sciences (NIEHS)). NIEHS had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: JK, YL and MWR are co-inventors on a provisional patent application being prepared by Harvard University. This does not alter the
authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: wessling@hsph.harvard.edu
Introduction
Divalent metal transporter-1 (DMT1) mediates uptake of
manganese across the olfactory epithelium into the brain [1]. It is
also the major transporter for iron absorption in the duodenum [2,3].
During iron deficiency, the transporter’s expression becomes up-
regulated in both olfactory and intestinal epithelia [1,2,4]. Thus, up-
regulation of DMT1 in iron-deficient rats is associated with increased
olfactory manganese uptake [1]. The physiological significance of
iron-responsive manganese transport to the brain has not been
explored. Enhanced manganese delivery to the brain promoted by
iron deficiency could have a toxic impact by modifying neurological
complications of poor iron status. Iron-deficient animals are
hypoactive [5,6], and decreased physical activity and impaired
skeletal motor activity are thought to be due to altered dopaminergic
function [5,7–11]. Manganese toxicity is also known to cause motor
deficits, and locura manganica or ‘‘manganese madness’’ is associated
with bradykinesia, rigidity, tremor and dystonia [12].
We speculated that impaired motor activity due to iron
deficiency might be negatively influenced by olfactory manganese
exposure due to iron-responsive uptake of the metal across the air-
brain-barrier. We therefore determined the distribution of
intranasally-instilled manganese in the brain of control and iron
deficient rats using magnetic resonance imaging (MRI) and
examined the functional interactions between manganese expo-
sure and iron deficiency, both of which can impair motor function.
Unexpectedly, the impaired motor function of iron-deficient rats
was corrected by olfactory manganese instillation. These effects
were associated with manganese-induced changes in dopamine
receptors and transporters that suggest altered post-synaptic
signaling compensates for motor impairments due to iron
deficiency. Iron-responsive manganese assimilation in the brain
serves as a ‘‘rescue response’’.
Results
Manganese instillation of iron-deficient rats
Iron deficiency was induced in weanling Sprague-Dawley rats
fed an iron-deficient diet (5 mg iron/kg) for 4 weeks. Physiological
and hematological parameters were evaluated at 7 weeks as shown
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(220 mg iron/kg), rats fed the iron-deficient diet weighed 11% less
(220 vs 248 g; P,0.05) although brain weight was similar between
both groups. Hematocrit values were significantly reduced (23.9 vs
44.1%; P,0.05) and non-heme iron levels in liver and serum were
lower (8.2 vs 43.2 mg/g and 0.28 vs 1.34 mg/mL, respectively;
P,0.05).
Two manganese dosing regimens were studied with the
maximum soluble amount (10 mg MnCl2/kg) instilled either 3
times across one week or 6 times across 3 weeks (total doses of
30 mg/kg or 60 mg/kg). Separately matched control and iron-
deficient diet cohorts were intranasally-instilled with vehicle alone
(distilled water). Intranasal instillation did not change body or
brain weight (Table 1). Hematological parameters were also
unaffected, although a slightly reduced hematocrit value was noted
in iron-deficient rats administered 60 mg MnCl2/kg compared to
water-instilled iron-deficient rats (Table 1).
Effect of iron deficiency on brain accumulation of
intranasally-instilled manganese
Magnetic resonance imaging was performed on isoflurane-
anesthetized rats using a 4.7T MR device to assess signal for brain
manganese on T1-weighted images. Fig. 1 presents the T1-
weighted images in axial sections for control and iron-deficient rats
intranasally-instilled with water or 30 mg MnCl2/kg two days
following the last instillation. Greater signal intensity in the brain,
particularly the olfactory bulb and the basal ganglia, was observed
in manganese-instilled rats compared with water-instilled controls,
confirming the signal is associated with the metal’s accumulation.
Cross-over of manganese from the right nostril (instillation site) to
the left hemisphere was more pronounced in iron-deficient rats,
with greater accumulation appearing in posterior regions including
the striatum (Fig. 1, arrowheads).
To directly compare the distribution of manganese in the brain
between control and iron-deficient rats, the signal intensity on the
T1-weighted images was corrected for the endogenous signal
intensity of the respective water-instilled diet group and normal-
ized to brain weight (Fig. 2). Signal intensity due to manganese in
the axial sections of the brain tissue was significantly enhanced in
an anterior-to-posterior fashion (Fig. 2A). Iron-deficient rats
displayed increased signal in specific brain regions including
prefrontal cortex, globus pallidus, and hippocampus. Although
regions closer to the nasal instillation site (i.e., olfactory bulb and
tract) showed a similar trend, the difference in signal was not
statistically significant (Fig. 2B). The combined signal intensity
calculated after integrating signal across all MRI sections
(1561 mm) of the whole brain was doubled in iron-deficient rats
instilled with either 30 or 60 mg MnCl2/kg (Fig. 2C, 3.36 vs 1.67
or 2.55 vs 1.16 intensity ratios, respectively; P,0.05). The fact that
signal intensity did not increase at the higher dose suggests a
saturation effect on olfactory uptake and/or accumulation of
metal. It should be noted that administered doses were based on
body weight, and intensity ratios may actually under-estimate the
true difference between control and iron-deficient brain manga-
nese accumulation, since brain weights were similar between the
two groups. The fact that manganese is eliminated very slowly
from the rat brain with a half-life .50 days [13,14], suggests that
elevated levels of manganese in iron-deficient rats result from
enhanced olfactory uptake rather than from reduced clearance
from the brain. However, other possible explanations of these data
include the fact that the MRI signal intensity may become
saturated such that higher Mn concentrations cannot be
distinguished. Alternatively, neurotoxic effects of Mn on the
transport process itself may interfere.
Effect of iron deficiency and olfactory manganese
instillation on motor coordination
To examine functional interactions between iron deficiency and
manganese exposure, a motor coordination study was carried out
using a standard rotarod device. Control and iron-deficient rats
were instilled with 60 mg MnCl2/kg or vehicle over 3 weeks as
Table 1. Physiological and hematological characteristics of rats treated with olfactory manganese under iron deficiency.
Control Iron-deficient
MnCl2 (mg/kg) 0 (N) 30 (N) 60 (N) 0 (N) 30 (N) 60 (N)
Body weight
{, g 248 6 6 (9) 238 6 8 (9) 239 6 4 (4) 220 6 6 (10) 198 6 7 (9) 201 6 3 (4)
Brain weight, g 1.87 6 0.08 (5) 1.82 6 0.06 (5) 1.94 6 0.03 (4) 1.80 6 0.03 (7) 1.81 6 0.04 (5) 1.82 6 0.01 (4)
Hematocrit
{,1, % 44.1 6 1.1 (9) 40.8 6 0.8 (9) 45.8 6 1.6 (4) 23.9 6 1.3 (10) 24.1 6 0.6 (9) 20.9 6 0.9 (4)
Liver non-heme iron
{, mg/g liver
43.2 6 2.2 (4) 44.5 6 6.4 (3) 44.0 6 4.6 (4) 8.2 6 0.3 (4) 8.3 6 1.4 (3) 7.2 6 0.9 (4)
Serum iron
{, mg/mL 1.34 6 0.16 (4) ND 1.37 6 0.12 (4) 0.28 6 0.07 (4) ND 0.36 6 0.11 (4)
Data are presented as the mean 6 SEM and were analyzed by two-way ANOVA; ND, not determined;
{P,0.05, effect of iron deficiency;
1P,0.05, effect of interaction between MnCl2 and iron deficiency.
doi:10.1371/journal.pone.0033533.t001
Figure 1. Manganese accumulation in the brain after intranasal
instillation. MnCl2 was instilled into the right nostril of rats three times
on days 1, 4, and 6 (30 mg/kg). Distilled water was used as a vehicle
control. Two days following the last instillation, MR images were taken
from isoflurane-anesthetized rats using a 4.7T MR device to assess
signal intensity on T1-weighted images of axial sections of the brain
with a thickness of 1 mm. Arrowheads indicate the striatum.
doi:10.1371/journal.pone.0033533.g001
Olfactory Manganese in Iron Deficiency
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33533described above, then tested for motor function and Fe x Mn
interactions. Manganese-instilled rats fed the control diet displayed
diminished motor coordination, however, iron-deficient rats
instilled with manganese stayed on the bar longer before falling
and displayed an increase in the maximum speed attained on the
rotarod (Fig. 3, A and B). The effect of Fe x Mn interaction was
significant (P=0.028) and showed an unexpected reversal of motor
impairment.
Effect of olfactory manganese exposure and iron
deficiency on striatal dopamine levels
To better understand the mechanistic basis for the observed
interactions between manganese exposure and iron deficiency on
motor function, levels of the neurotransmitter dopamine were
determined in the striatum, a brain region associated with motor
control and coordination. Tissue dopamine concentrations in
control and iron-deficient rats were similar and unaffected by
intranasal instillation of 60 mg MnCl2/kg (Fig. 4A). Microdialysis
experiments determined resting extracellular dopamine concentra-
tions did not differ significantly among water-instilled or manga-
nese-instilled controland iron-deficient cohorts (Fig. 4B). While the
fold-change in K
+-stimulated dopamine release did not differ
significantly (Fig. 4C), amphetamine-evoked release increased
extracellular dopamine levels 14-fold in control and 18-fold in
iron-deficient rats. Iron-deficient rats instilled with 60 mg MnCl2/
kg had a 24-fold increase in amphetamine-stimulated extracellular
dopamine (Fig. 4D) with a significant Fe x Mn effect (P=0.047).
Effect of olfactory manganese exposure and iron
deficiency on striatal dopamine transporter and receptor
levels
To determine whether manganese exposure influenced the
expression of dopamine transporters and receptors in the striatum,
Western blot analysis was used to quantify protein levels.
Intranasal manganese instillation reduced dopamine transporter
(DAT) and dopamine receptor D1 (D1R) levels (Fig. 5, A and B)
while dopamine receptor D2 (D2R) levels were increased (Fig. 5C).
These manganese-induced changes were the same in control and
iron-deficient rats.
Discussion
The most relevant route for occupational and environmental
manganese exposure health effects is through inhalation [15].
Characterization of the influence of iron status on olfactory and
pulmonary manganese transport has demonstrated that respirato-
ry manganese uptake reflects iron stores [1,16,17] and that DMT1
is involved in absorption across the olfactory epithelium into the
brain [1]. Here, we studied interactions between systemic iron
status, olfactory manganese uptake, and brain manganese
deposition on neurobehavioral function and dopamine neuro-
transmission in the striatum. Rats fed a low iron diet during the
course of this study had similar brain weights, although iron
deficient rats had lower body weights compared to control rats.
Hematocrit, liver non-heme iron and serum iron values were all
Figure 2. Effects of iron deficiency on manganese accumulation in the brain after intranasal instillation. After intranasal instillation of
MnCl2 (3610 mg/kg for 1 wk or 6610 mg/kg for 3 wks), a signal intensity ratio of brain to the background for each image was calculated and
corrected for endogenous signal intensity of respective diet group and then normalized to brain weight and dose. Manganese distribution in the axial
sections of the brain tissue (A), in specific brain regions (B) and in the whole brain integrating all sections (C) was compared between control and
iron-deficient rats. Empty and closed bars represent water-instilled and MnCl2-instilled rats, respectively. Data were presented as mean 6 SEM (N=4–
5). * P,0.05 between control and iron-deficient rats determined by two-sample t-test. OB, olfactory bulb; OTR, olfactory tract; OTB, olfactory tubercle;
PFC, prefrontal cortex; CPU, caudate-putamen or striatum; GP, globus pallidus; CTX, cortex; HPC, hippocampus.
doi:10.1371/journal.pone.0033533.g002
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of our study was to better understand the consequences of
enhanced olfactory manganese absorption under these conditions
of low body iron status.
Manganese is taken up from the nasal cavity along the olfactory
tract into the brain [1,18–20]. Using T1-weighted MR imaging,
we determined brain manganese distribution after intranasal
instillation of 30 and 60 mg MnCl2/kg body weight. A strong
anterior-to-posterior trend of manganese-associated signal inten-
sity on T1-weighted images was observed. These results generally
agree with earlier studies using radioactive tracer to map uptake
and transport from the olfactory bulb into the brain [1,18,19,21].
It has been proposed that divalent manganese acts as a calcium
ortholog and is taken up into synaptic vesicles that undergo
anterograde transport in a microtubule-dependent (colchicine-
sensitive) manner for its subsequent distribution [22], which
explains relatively low accumulation of manganese in the olfactory
bulb in our study. Iron deficiency has been shown to increase
brain manganese deposition when administered through diet or by
intravenous injection thereby following a pathway across the
Figure 3. Effect of iron deficiency and manganese exposure on motor coordination of the rat. Rats were pair-fed, intranasally instilled
(6610 mg/kg) for 3 wks, and tested on the rotarod device to record the time to falling-off (A) and speed of the rod (B). Empty and closed bars
represent water-instilled and MnCl2-instilled rats, respectively. Data were presented as mean 6 SEM (N=3–4 per group) and were analyzed using
two-way ANOVA.
doi:10.1371/journal.pone.0033533.g003
Figure 4. Effect of iron deficiency and manganese instillation on dopamine turnover in the striatum. Immediately after rotarod test
(Fig. 3), rats were euthanized and striatal tissues were homogenized to determine the tissue concentrations of dopamine (A; N=3–4). Rats of
another cohort were anesthetized with urethane and microdialysis was performed to determine the basal dopamine concentration at resting state (B;
N=6–8) and the fold-change in AUC of dopamine release either after high K
+ (30 mM) stimulation (C; N=6–8) or after amphetamine stimulation
(1 mg/kg, s.c.) in striatal extracellular fluid (D; N=6–8). Empty and closed bars represent water-instilled and MnCl2-instilled rats, respectively. Data
were presented as mean 6 SEM and were analyzed using two-way ANOVA.
doi:10.1371/journal.pone.0033533.g004
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is the first to use MRI to map the olfactory route across the air-
brain-barrier under iron deficiency conditions, and our results
demonstrate that brain manganese is doubled in iron deficient rats
compared to controls after one week of intranasal instillation (total
dose of 30 mg MnCl2/kg). Significantly greater signal intensities
were observed in the prefrontal cortex, caudate putamen, globus
pallidus, cortex and hippocampus. Our previous isotopic tracer
kinetic study demonstrated that brain uptake of manganese after
intranasal instillation was more than 20-fold greater than after
intravenous injection. Combined, these separate lines of evidence
indicate that manganese transport via the air-brain-barrier is by
far more efficient than transfer across the blood-brain-barrier and
is significantly up-regulated as a result of systemic iron deficiency
[1].
Because the ratio of signal intensity to brain weight did not
increase with continued dosing from 1 to 3 weeks, the mechanism
responsible for metal absorption and accumulation from the
olfactory pathway appears to be saturable. Increased manganese
accumulation in iron-deficient rats could be explained by greater
olfactory uptake of metal into the brain and/or by increased
number of iron-responsive metal-binding sites. We have previously
shown that olfactory uptake of
54Mn to the brain is enhanced by
low iron status but it is significantly reduced in Belgrade rats with
DMT1 deficiency [1]. It is therefore likely that manganese
distribution mapped by MRI reflects changes in levels of this
transporter in the olfactory epithelium, although it is also possible
that manganese binding sites or other transport pathways
secondary to increased manganese entry across the olfactory
epithelium are enhanced by iron deficiency. Other possibilities
discussed above include neurotoxic effects of manganese on
retrograde transport from the nasal cavity to the brain. Further
studies are warranted to examine manganese binding sites by
radioactive uptake and metal distribution, for example.
Motor impairments due to iron deficiency are well documented
[10] and behavioral effects due to excess dietary manganese have
been reported [25,26]. Both the time on bar before falling and the
maximum speed attained on the rotarod were reduced in control
rats intranasally-instilled with manganese, and both of these
functions were more severely impaired in iron-deficient rats.
However, the observation that intranasal manganese instillation of
iron-deficient rats improved performance with a significant Fe x
Mn interaction (two-way ANOVA, P=0.028) was unexpected.
This evidence points to a beneficial influence of iron-responsive
manganese uptake to the brain – a ‘‘rescue response’’ triggered
under low iron conditions.
To explore the underlying basis for behavioral Fe x Mn
interactions, dopamine metabolism and signaling in the striatum
was examined. Both high manganese [27] and iron deficiency
[7,8] alter dopamine turnover and metabolism. Under our
experimental conditions, striatal dopamine levels were similar
between control and iron-deficient rats. While some investigations
have shown that tissue dopamine levels are altered by iron
deficiency, differences in age, circadian cycle, extent of iron
depletion, and duration of low iron status between various study
groups have led to inconsistent results [5,7,10,11,28]. Likewise,
chronic manganese exposure to the brain across the blood-brain-
barrier is thought to diminish dopamine levels [29–31], but the
olfactory exposure used in our study did not appear to perturb
dopamine content, possibly because metal accumulation was
lower, manganese deposition was regionally different, and/or the
duration of manganese exposure (1–3 weeks) was less than
previously studied [29–31]. We also studied changes in release
and turnover of extracellular dopamine by microdialysis. It has
been reported that extracellular dopamine is increased in iron-
deficient animals as a consequence of reduced uptake by DAT
[9,11]. Under our study conditions, DAT levels were the same in
control and iron-deficient rats, but protein levels were reduced by
Figure 5. Effect of iron deficiency and manganese instillation on the expression of dopamine transporters and receptors in the
striatum. Rats intranasally instilled with MnCl2 (6610 mg/kg) were euthanized and striatal tissues were collected and homogenized to determine
the expression levels of dopamine transporter (DAT; A), dopamine receptor D1 (D1R; B), and dopamine receptor D2 (D2R; C). Relative intensities of
protein bands normalized to actin were determined using Odyssey software (version 2.1). Empty and closed bars represent water-instilled and MnCl2-
instilled rats, respectively. Data were presented as mean 6 SEM (N=3–4 per group) and were analyzed using two-way ANOVA.
doi:10.1371/journal.pone.0033533.g005
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manganese exposure have been reported in studies of chronic
administration by diet [29] or injection [30]. Our study indicates
olfactory administration of manganese can also down-regulate
DAT, possibly in a more acute manner.
Consistent with reduced DAT, microdialysis measurements
showed that extracellular resting dopamine was slightly increased
in the manganese-exposed groups and K
+-stimulated levels were
higher, but neither of these effects was statistically significant. In
contrast, extracellular dopamine increased in response to amphet-
amine with a significant Fe x Mn interaction (two-way ANOVA,
P=0.047). Manganese has been shown to modify amphetamine-
induced responses but the precise mechanism is unknown [27]. It
is interesting to speculate that the underlying basis for the observed
pharmacological Fe x Mn interaction could reflect compensatory
changes in iron-deficient rats induced by olfactory manganese
exposure that restored normal activity in the motor tests
performed on this group. In particular, manganese might not
only modulate DAT levels but the metal could influence its
function by direct competition or by other non-competitive
interactions. It has been shown that some DAT inhibitors
negatively affect manganese uptake by striatial tissue [32,33],
and manganese inhibits dopamine uptake by synaptosomes
[32,34].
Alternatively, olfactory manganese exposure may modulate
downstream signaling by altering dopaminergic receptors. There is
evidence indicating iron deficiency disrupts dopaminergic func-
tions by reducing D1R and D2R levels [9,28]. Although we did
not observe statistically significant effects on dopamine receptor
levels due to iron deficiency, olfactory manganese exposure
significantly reduced D1R and increased D2R levels in both
control and iron-deficient rats. These results are in good
agreement with previous findings reported for gestational/
lactational exposures to manganese [35,36]. Overall, this evidence
suggests that olfactory manganese exposure up-regulates post-
synaptic signaling through D2R, which may compensate for loss of
dopaminergic signaling under iron-deficient conditions.
Finally, it should be recognized that multiple pathways could be
involved in the interaction between brain iron deficiency and the
monoaminergic system, and that many metal-containing enzymes
and/or cellular components contribute to this process. It is
conceivable that increased availability of manganese affords the
replacement of iron to rescue the loss of certain iron-dependent
enzymatic or structural functions. For example, both iron and
manganese have been shown to support activity of tyrosine
hydroxylase, the rate-limiting enzyme for dopamine synthesis [37].
In fact, the idea that unoccupied metal binding sites are available
under iron deficiency to bind excess manganese and limit the
metal’s toxicity is compatible with the Fe x Mn interactions
observed in our study.
Our data confirm that both iron and manganese play active
roles in modulating motor function. Contrary to our speculation
that manganese might exacerbate functional losses due to iron
deficiency, our study suggests iron-responsive olfactory manganese
uptake confers a beneficial response to low iron status. Along
similar lines, the protective nature of manganese associated with
iron homeostasis and oxidative stress defense recently has emerged
for bacteria [38] and yeast [39]. The pathways responsible for
iron-responsive olfactory uptake of manganese and the metal’s
impact on dopaminergic function warrant further exploration as a
possible course of therapeutic intervention for conditions wherein
iron deficiency promotes functional deficits (e.g., restless legs
syndrome) or loss of dopaminergic function impacts motor
coordination and control (e.g., Parkinson’s disease).
Materials and Methods
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
approved by the Harvard Medical Area Animal Care and Use
Committee (Animal Experimentation Protocol AEP #03769).
Animals and diets
Weanling Sprague-Dawley rats (Taconic) were fed either control
chow (220 mg iron/kg, PicoLab 5053, PharmaServ) or iron-
deficient diet (5 mg/kg, TD99397, Harlan Teklad) for 4 weeks to
establish controlandiron-deficientcohorts[1,16].Bothgroupswere
fed ad libitum for MRI studies of brain manganese distribution. Iron-
deficient rats were fed ad libitum for behavioral and neurotransmitter
analyses while control rats were pair-fed to match body weight for
these experiments. Rats were intranasally instilled with MnCl2
(Sigma-Aldrich) into the right nostril withthin gel loadingtips under
isoflurane anesthesia. Distilled water (vehicle) was used as an
instillation control. Two dosing regimens (1 and 3 weeks) were
studied: 6-wk-old rats were instilled with 10 mg MnCl2/kg three
times at days 1, 4, and 6 (a total of 30 mg/kg), whereas, for three-
week treatment, 4-wk-old rats were instilled with 10 mg MnCl2/kg
twice weekly at days 1, 5, 8, 12, 15, and 19 (a total of 60 mg/kg).
Thisdose schedule permitted sufficient distribution of manganese to
the brain but because iron homeostasis is influenced by circadian
rhythm, we instilled manganese in the morning (every 2–3 days).
Timing was limited to short duration exposure to severe iron
deficiency. At the end of the study, rats were euthanized by
isoflurane overdose followed by exsanguination for collection of
blood, liver, and brain tissues to analyze iron status.
MR imaging and analysis
Anesthetized rats were placed in a 4.7T MR device and
immediately imaged for 30–60 min to obtain multi-slice T1-
weighted images covering entire brain in both axial and sagittal
sections 1 mm thick (gapless). The echo time/repetition time used
was 500/11 msec and the field of view was 363c m
2 yielding a
resolution of 120 mm. Signal intensity was measured and
normalized to background signal intensity using ImageJ software
(NIH, version 1.44). The endogenous averaged signal intensity
ratio values of vehicle-treated animals of the respective diet group
were subtracted to determine signal due to instilled manganese
uptake. The manganese signal intensity ratio was finally
normalized to post-mortem brain weight. Manganese distribution
in the brain including specific brain regions (e.g., prefrontal cortex,
globus pallidus, etc), total brain tissue of each section (2-
dimensional), and integration of whole brain sections (3-dimen-
sional) was compared between control and iron-deficient rats.
Rotarod test
Pair-fed rats (3–4 per group) instilled with water or 60 mg
MnCl2/kg as described above were placed on a standard
accelerating rotarod device (Harvard Apparatus). Following 3-
day training sessions at fixed speeds, rats were tested twice on the
rotarod with accelerating speeds from 4 to 40 rpm over 5-min
(maximum time on bar) or until the animals fell off. Time on bar
and speed attained on rotarod before falling were recorded, and
the better score of the two trials was used for analysis.
Microdialysis
Rats (6 to 8 per group) were anesthetized with urethane (1 g/kg,
i.p.) and placed in a stereotaxic apparatus (Stoelting). A mid-
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drilled to allow for implantation of a guide cannula and a
precalibrated 3-mm concentric microdialysis probe (CMA-12
Elite, CMA/Microdialysis) into the right striatum (Bregma:
AP+0.7 mm, LR–2.8, DV–6.8). Following probe implantation,
artificial cerebrospinal fluid (K
+ 2.7 mM) was continuously
perfused (2 mL/min) with an infusion pump (Harvard Apparatus)
for 2 hrs to allow for stabilization of injury-mediated release of
neurotransmitters, after which 4 baseline samples (20-min each)
were collected to determine resting levels of dopamine. Samples
were collected for an additional 60–80 min during perfusion of
fluid containing 30 mM K
+ or after subcutaneous injection of
1 mg/kg d-amphetamine to stimulate dopamine efflux. Micro-
dialysates were mixed with 5 mL of 0.1 M acetic acid containing
oxalic acid (1.0 mM) and L-cysteine (3.0 mM) to prevent oxidative
degradation of monoamines [40] and stored at 280u until HPLC
analysis. The area under the concentration-time curve (AUC)
analysis was employed to determine d-amphetamine-induced
dopamine release [41].
Analysis of dopamine in microdialysates
The HPLC system consisted of an ESA 542 autosampler (ESA,
Thermo Fisher, Waltham, MA), an ESA 582 dual-piston pump, a
Capcell PAK MG C18 column (5061.5 mm, 3 mm particles, ESA),
an ESA Coulochem III detector, with a 5020 guard cell and a
5041 amperometric analytical cell. The guard cell was set at a
potential of +275 mV and the 5041 analytical cell was set to
+220 mV. Data were acquired from the 5041 analytical cell and
analyzed with EZChrom Elite software configured for the
Coulochem III system by ESA. The mobile phase contained
150 mM sodium dihydrogen phosphate monohydrate and
4.76 mM citric acid monohydrate, adjusted to pH 5.6 with
concentrated semiconductor grade sodium hydroxide before
adding 3 mM sodium dodecyl sulfate, 50 mM EDTA, 10%
methanol (v/v) and 15% acetonitrile (v/v), in NANOpure water
prefiltered first through a C18 cartridge (Sep-Pak, Waters, Milford,
MA) then through a 0.2 mm nylon membrane (Millipore,
Burlington, MA). The flow rate was 0.2 mL/min and the column
was kept at 29uC. Calibration was by external standards prepared
in solutions of 0.2 M HClO4, 0.2 mMN a 2EDTA and 0.2 mM
ascorbic acid [42]. Concentration/area calibrations were linear
over the concentration ranges found in the microdialysates, with
r
2.0.999. The detection limit was approximately 10 pg/mL.
Analysis of dopamine in tissue homogenates
Striatal tissue homogenates were prepared in ice cold 0.2 M
perchloric acid (1:10 w/v) containing ascorbic acid (0.2 mM) and
EDTA (0.2 mM) and centrifuged for 6 min at 15,0006g. An
aliquot of the supernatant was further diluted 1:2 in perchloric
acid solution and centrifuged for an additional 2 min at 15,0006g,
and final supernatant (10 mL) was analyzed using an HPLC system
consisting of an ESA 542 autosampler (ESA), an ESA 580 dual-
piston pump, an ESA MD-150 column (C18, 15063.2 mm, 3 mm
particles, 120 A ˚ pores), an ESA Coulochem II detector (Model
5200), with a 5020 guard cell and a 5011 coulometric analytical
cell. The potentials of the electrochemical cells were EGuardCell
+350 mV, E1 2150 mV and E2 +300 mV, all against a palladium
reference electrode. Data were acquired from E2 and analyzed by
PC/Chrom+ software (H & A Scientific, Greenville, NC). The
mobile phase consisted of 90 mM sodium phosphate monobasic
monohydrate; 50 mM citric acid monohydrate; 1.7 mM 1-
octanesulfonic acid sodium salt hydrate, HPLC grade; 50 mM
disodium ethylenediamine tetraacetate dihydrate; and 10%
acetonitrile (v/v) in water prefiltered as described above. The
flow rate was 0.4 mL/min. Calibration was by external standards
prepared in solutions of the above preservative. Concentration/
area calibrations were linear over the ranges of concentrations
found in the microdialysates, with r
2.0.999.
Western blot analysis of dopamine transporters and
receptors
Microdissected striatal regions were homogenized in Tris-NP40
buffer (50 mM Tris-HCl, 150 mM NaCl, 0.5% NP40, pH 7.5)
containing protease inhibitors (Complete Mini, Roche). Samples
(50–100 mg proteins) were electrophoresed on a 10% SDS-
polyacrylamide gel and transferred to polyvinylidene difluoride
membrane (Millipore). After blocking, the membrane was
incubated in goat anti-dopamine transporter (DAT) antibody
(1:100, Santa Cruz), mouse anti-dopamine receptor D2 (D2R)
antibody (1:100, Santa Cruz) or rat anti-dopamine receptor D1
(D1R) antibody (1:100, Sigma). As a control for loading, the
immunoblot was also incubated with mouse anti-actin (1:10,000,
MP Biomedicals). The blots were incubated with IRDye800/680-
conjugated secondary antibody (1:10,000, Li-COR) and scanned
using an Odyssey Infrared Imaging System (Li-COR). Relative
intensities of protein bands normalized to actin were determined
using Odyssey software (version 2.1).
Statistical analyses
Values reported were expressed as means 6 SEM. For two-
group comparison (MRI analysis), two-sample t-test was employed.
To determine interaction effects of iron deficiency and olfactory
Manganese exposure as well as individual main effects, a two-way
ANOVA was performed using Systat 13 (Systat). Differences were
considered significant at P,0.05.
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